Unknown

Dataset Information

Targeting the Immune System for Pulmonary Inflammation and Cardiovascular Complications in COVID-19 Patients.


ABSTRACT: In December 2019, following a cluster of pneumonia cases in China caused by a novel coronavirus (CoV), named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the infection disseminated worldwide and, on March 11th, 2020, the World Health Organization officially declared the pandemic of the relevant disease named coronavirus disease 2019 (COVID-19). In Europe, Italy was the first country facing a true health policy emergency, and, as at 6.00 p.m. on May 2nd, 2020, there have been more than 209,300 confirmed cases of COVID-19. Due to the increasing number of patients experiencing a severe outcome, global scientific efforts are ongoing to find the most appropriate treatment. The usefulness of specific anti-rheumatic drugs came out as a promising treatment option together with ant

SUBMITTER: Colafrancesco S 

PROVIDER: S-EPMC7324709 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature